Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Crossject Société Anonyme, headquartered in France, is a pioneering company in the pharmaceutical industry, specialising in the development of innovative drug delivery systems. Founded in 2007, Crossject has made significant strides in creating its unique needle-free injection technology, which enhances patient comfort and compliance.
The company focuses on several therapeutic areas, including pain management and emergency medicine, with its flagship product, Zeneo, designed to provide rapid and effective medication delivery. Crossject's commitment to innovation has positioned it as a leader in the market, with notable achievements in securing partnerships and advancing its product pipeline. With operations extending across Europe and beyond, Crossject continues to redefine the standards of drug administration, making healthcare more accessible and efficient.
-16 vs industry average
Crossject Société Anonyme’s score of 16 is lower than 43% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Medical Device Manufacturing has below-average carbon intensity
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
No reported emissions data is available for Crossject Société Anonyme yet.
Crossject Société Anonyme, headquartered in France, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and commitments suggests that Crossject may not yet have established a formal framework for addressing its carbon footprint or engaging in climate action initiatives. As the industry increasingly prioritises sustainability, it will be essential for Crossject to consider developing and communicating its climate commitments to align with global standards and expectations.
No climate goals have been disclosed for Crossject Société Anonyme yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more